Access to cancer medicines deemed essential by oncologists in 82 countries

Bishal Gyawali

The Lancet Oncology, 09/21/2021

VIVIO clinical team member, Bishal Gyawali, MD, PhD, is part of the team that develops the WHO Essential Medicines List (EML) identifies priority medicines that are most important to public health. Over time, the EML has included an increasing number of cancer medicines. See the details of their ground breaking work.